Genetic Aspects of Amyloidosis

  • Daniel R. Jacobson
  • Joel N. Buxbaum
Part of the Advances in Human Genetics book series (AHUG, volume 20)


The amyloidoses are diseases characterized by the extracellular accumulation of insoluble protein fibrils. From the initial pathologic description by Virchow in the mid-19th century until the early 1970s, the idea of a single amyloid substance was dominant, and the systemic amyloid syndromes were classified on clinical grounds, i.e., the anatomic distribution of amyloid deposition and the associated clinical findings. The most widely accepted nosology acknowledged only three basic types of systemic amyloidosis, “secondary,” “familial,” and “primary” (in addition to rare forms of amyloidosis localized to a single organ). Thus, deposits of amyloid material in the kidney, liver, and spleen in association with chronic inflammatory processes such as tuberculosis and rheumatoid arthritis were termed “secondary amyloidosis.” Familial amyloidosis was recognized by its distinctive clinical manifestations and the positive family history. All other types of amyloidosis, except that associated with the neoplasm multiple myeloma, were termed “primary,” in the sense of “idiopathic”; this category included unrecognized inherited forms, “secondary” amyloidosis without an identified cause, and localized amyloidoses. The failure of many instances of amyloid deposition to fit neatly into the prescribed clinical and histologic categories should have suggested that the notion of a unique amyloid substance was conceptually inadequate.


Familial Mediterranean Fever Amyloid Fibril Cardiac Amyloidosis Familial Mediterranean Fever Patient Familial Amyloid Polyneuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abrahamson, ML, Quamrul Islam, M., Szpirer, J., Szpirer, C., and Levan, G., 1989, The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy located on chromosome 20, Hum. Genet. 82: 223–226.PubMedGoogle Scholar
  2. Alexander, F., and Atkins, E. L., 1975, Familial renal amyloidosis, Am. J. Med. 59: 121–128.PubMedGoogle Scholar
  3. Al-Hashimi, I., Dickinson, D. P., and Levine, M. J., 1988, Purification, molecular cloning, and sequencing of salivary cystatin SA-I, J. Biol. Chem. 263: 9381–9387.PubMedGoogle Scholar
  4. Alkalay, I., Shanfeld, M., and Levy, E., 1959, Familial periodic disease with renal damage, J. Am. Med. Assoc. 170: 653–655.PubMedGoogle Scholar
  5. Almeida, M. R., Gawinowicz, M. A., Costa, P. P., Salvi, F., Ferlini, A., Plasmati, R., Tassinari, C., and Saraiva, M. J., 1990a, A new transthyretin variant associated with familial amyloidotic polyneuropathy in an Italian kindred, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 127.Google Scholar
  6. Almeida, M. R., Costa, P. P., and Saraiva, M. J., 19906, A TTR acidic variant: DNA analyses of homozygous and heterozygous individuals, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 1265.Google Scholar
  7. Andrade, C., 1952, A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves, Brain 75: 408–427.PubMedGoogle Scholar
  8. Anis, M., McAdam, K. P. W. J., Broadbent, P., and Raynes, J. G., 1990, Dopamine -hydroxylase in familial Mediterranean fever, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 144.Google Scholar
  9. Anzai, N., Akyiyama, K., Ysuchida, K., Yamada, M., Kito, S., and Yamamura, Y., 1989, Treatment by pacemaker in familial amyloid polyneuropathy, Chest 96: 80–84.PubMedGoogle Scholar
  10. Araki, S., Mawatari, S., Ohta, M., Nakajima, A., and Kuroiwa, Y., 1968, Polyneuritic amyloidosis in a Japanese family, Arch. Neurol. 18: 593–602.PubMedGoogle Scholar
  11. Arapakis, G., and Tribe, C. R., 1963, Amyloidosis in R.A. investigated by means of rectal biopsy, Ann. Rheum. Dis. 22: 256–262.PubMedGoogle Scholar
  12. Arnason, A., 1935, Apoplexic und ihre verebung, Acta Psychiatr. Neurol. Suppl. VII 1935: 1–180.Google Scholar
  13. Barakat, M. H., El-Khawad, A. O., Gumaa, K. A., El-Sobki, N. I., and Ferrera, F. F., 1984, Metaraminol provocation test: A specific diagnostic test for FMF, Lancet 1: 616–617.Google Scholar
  14. Barakat, M. H., Karnik, A. M., Magud, H. W., al Sobks, N. I., and Fencal, F. F., 1986, Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs: A study of 175 patients and review of the literature, Q. J. Med. 60: 837–847.PubMedGoogle Scholar
  15. Barakat, M. H., Gumaa, K. A., Malhas, L. N., El-Sobki, N. I., Monssa, M. A., and Tencal, F. F., 1988, Plasma dopamine beta hydroxylase: Rapid diagnostic test for recurrent hereditary polyserositis, Lancet 2: 1280–1283.PubMedGoogle Scholar
  16. Barrett, A. J., Davies, M. E., and Grubb, A., 1984, The place of human gamma-trace (Cystatin C) amongst the cysteine proteinase inhibitors, Biochem. Biophys. Res. Commun. 120: 631–636.PubMedGoogle Scholar
  17. Benson, M. D., 1988, Hereditary amyloidosis — Disease entity and clinical model, Hosp. Prac. 1988: 165–181.Google Scholar
  18. Benson, M. D., and Cohen, A. S., 1977, Generalized amyloid in a family of Swedish origin, Ann. Intern. Med. 86: 419–424.PubMedGoogle Scholar
  19. Benson, M. D., and Dwulet, F. E., 1983, Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis, Arthritis Rheum. 26: 1493–1498.PubMedGoogle Scholar
  20. Benson, M. D., and Dwulet, F. E., 1985, Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I, J. Clin. Invest. 75: 71–75.PubMedGoogle Scholar
  21. Benson, M. D., Dwulet, F. E., Scheinberg, M. A., and Greipp, P., 1986, Chemical classification of hereditary amyloidosis in Brazilian families and identification of gene carriers, J. Rheumatol. 13: 927–931.PubMedGoogle Scholar
  22. Benson, M. D., Wallace, M. R., Tejada, E., Baumann, H., and Page, B., 1987, Hereditary amyloidosis: Description of a new American kindred with late onset cardiomyopathy, Arthritis Rheum. 30: 195–200.PubMedGoogle Scholar
  23. Bergman, F., and Warmenius, S., 1968, Familial perireticular amyloidosis in a Swedish family, Am. J. Med. 45: 601–606.PubMedGoogle Scholar
  24. Betts, J. C., and Woo, P., 1990, Characterization of the human SAA gene family, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 76.Google Scholar
  25. Bird, A. P., 1980, DNA methylation and the frequency of CpG in animal DNA, Nucleic Acids Res. 8: 1499–1504.PubMedGoogle Scholar
  26. Bird, T. D., and Lampe, T. H., 1989, Neurogenetics and familial Alzheimer’s disease, in: Familial Alzheimer’s Disease: Molecular Genetics and Clinical Perspectives ( D. Miner, R. Richter, J. P. Blass, J. L. Valentine, and L. A. Miner, eds.), Marcel Dekker, New York, pp. 15–24.Google Scholar
  27. Blake, C. C. F., Geisow, M. J., and Oatley, S. J., 1978, Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A, /. Mol. Biol. 121: 339–356.Google Scholar
  28. Blum, A., Gafni, J., Sohar, E., Shiholet, S., and Heller, H., 1962, Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF): Further evidence of its genetic nature, Ann. Intern. Med. 57: 795–799.PubMedGoogle Scholar
  29. Bouroncle, B. A., and Doan, C. A., 1957, Periodic fever: Occurrence in 5 generations, Am. J. Med. 23: 502–506.PubMedGoogle Scholar
  30. Brzin, J., Popovic, T., and Turk, V., 1984, Human cystatin, a new protein inhibitor of cysteine proteinases, Biochem. Biophys. Res. Commun. 118: 103–109.PubMedGoogle Scholar
  31. Buerger, L., and Braunstein, H., 1960, Senile cardiac amyloidosis, Am. J. Med. 28: 357–367.PubMedGoogle Scholar
  32. Burger, P. C., and Vogel, F. S., 1973, The development of the pathologic changes of Alzheimer’s disease and senile dementia in patients with Downs syndrome, Am. J. Pathol. 73: 457–476.PubMedGoogle Scholar
  33. Buxbaum, J., 1986, Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture, J. Clin. Invest. 78: 798–806.PubMedGoogle Scholar
  34. Cavallaro, T., Martone, R. L., Dwork, A. J., Schon, E. A., and Herbert, J., 1990, The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye, Invest. Ophthalmol. Vis. Sci. 31: 497–501.PubMedGoogle Scholar
  35. Chang, C. M., Yu, Y. L., Wong, M., Ng, T. H. K., Woo, E., and Huang, C. Y., 1989, Type I familial amyloid polyneuropathy in a Chinese family, Acta Neurol. Scand. 79: 391–396.PubMedGoogle Scholar
  36. Christmanson, L., Betsholtz, C., Gustavsson, A., Johansson, A., Sletten, K., and Westermark, P., 1991, The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis, FEBS Lett. 281: 177–180.PubMedGoogle Scholar
  37. Cohen, D. H., Feiner, H., Jensson, O., and Frangione, B., 1983, Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroenteropancreatic neuroendocrine protein, gamma trace, J. Exp. Med. 158: 623–628.PubMedGoogle Scholar
  38. Cooper, D. N., and Krawczak, M., 1990, The mutational spectrum of single base-pair substitutions causing human genetic disease: Patterns and predictions, Hum. Genet. 85: 55–74.PubMedGoogle Scholar
  39. Cooper, D. N., and Youssoufian, H., 1988, The CpG dinucleotide and human genetic disease, Hum. Genet. 78: 151–155.PubMedGoogle Scholar
  40. Cornwell, G. G., Ill, Murdoch, W. L., Kyle, R. A., Westermark, P., and Pitkanen, P., 1983, Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation, Am. J. Med. 75: 618–623.Google Scholar
  41. Costa, P. P., Figueira, A. S., and Bravo, F. R., 1978, Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy, Proc. Natl. Acad. Sci. USA 75: 4499–4503.PubMedGoogle Scholar
  42. Costa, R. H., Grayson, D. R., Xanthopoulos, K. G., and Darnell, J. E., 1988, A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha!-antitrypsin, albumin, and simian virus 40 genes, Proc. Natl. Acad. Sci. USA 85: 3840–3844.PubMedGoogle Scholar
  43. Costa, R. H., Lai, E., and Darnell, J. E., 1986, Transcriptional control of the mouse prealbumin (transthyretin) gene: Both promoter sequences and a distinct enhancer are cell specific, Mol. Cell. Biol. 6: 4697–4708.PubMedGoogle Scholar
  44. Dahlin, D. C., and Edwards, J., 1949, Amyloid localized in the heart, Mayo Clin. Proc. 24: 89–98.Google Scholar
  45. De Jager, H., and Stam, F. C., 1962, Pathology and histochemistry of amyloidosis in old age, Gerontologia 6: 19–35.PubMedGoogle Scholar
  46. Delabar, J. M., Goldgaber, D., Lamour, Y., Nicole, A., Huret, J. L., De Grouchy, J., Brown, P., Gajdusek, C., and Sinet, P. M., 1987, 0 amyloid gene duplication in Alzheimer’s disease and karyotypically normal Down syndrome, Science 235: 1390–1392.Google Scholar
  47. Dhillon, V., Woo, P., and Isenberg, D., 1989, Amyloidosis in the rheumatic diseases, Ann. Rheum. Dis. 48: 696–701.PubMedGoogle Scholar
  48. Dickson, P. W., Howlett, G. J., and Schreiber, G., 1985, Rat transtyhretin (prealbumin), J. Biol. Chem. 260: 8214–8219.PubMedGoogle Scholar
  49. Doft, B. H., Rubinow, A., and Cohen, A. S., 1984, Immunocytochemical demonstration of prealbumin in the vitreous in heredofamilial amyloidosis, Am. J. Ophthalmol. 97: 296–300.PubMedGoogle Scholar
  50. Dwork, A. J., Cavallaro, T., Martone, R. L., Goodman, D. S., Schon, E. A., and Herbert, J., 1990, Distribution of transthyretin in the rat eye, Invest. Ophthalmol. Vis. Sci. 31: 489–496.PubMedGoogle Scholar
  51. Dwulet, F. E., and Benson, M. D., 1983, Polymorphism of human plasma thyroxine binding prealbumin, Biochem. Biophys. Res. Commun. 114: 657–662.PubMedGoogle Scholar
  52. Dwulet, F. E., and Benson, M. D., 1984, Primary structure of an amyloid prealbumin and its plasma precurson in a heredofamilial polyneuropathy of Swedish origin, Proc. Natl. Acad. Sci. USA 81: 694–698.PubMedGoogle Scholar
  53. Dwulet, F. E., and Benson, M. D., 1986, Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss), J. Clin. Invest. 78: 880–886.PubMedGoogle Scholar
  54. Ehrenfeld, E. N., Eliakim, M., and Rachmilewitz, M., 1961, Recurrent polyserositis (Familial Mediterranean fever: Periodic disease): Report of 55 cases, Am. J. Med. 31: 107–123.Google Scholar
  55. Eliakim, M., 1970, Incidence of amyloidosis in recurrent polyserositis, Isr. J. Med. Sci. 6: 2–8.PubMedGoogle Scholar
  56. Eriksson, P., Eriksson, A., Backman, C., Hofer, P. A., and Olofsson, B. O., 1985, Highly refractile myocardial echoes in familial amyloidosis with polyneuropathy. A correlative echocardiographic and histopathological study, Acta Med. Scand. 217: 27–32.PubMedGoogle Scholar
  57. Eriksson, P., Boman, K., Jacobsson, B., and Olofsson, B. O., 1986, Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia, Acta Anaesthesiol. Scand. 30: 317–320.PubMedGoogle Scholar
  58. Eriksson, P., Backman, C., Eriksson, A., Eriksson, S., Karp, K., and Olofsson, B. O., 1987, Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy, Acta Med. Scand. 221: 39–46.PubMedGoogle Scholar
  59. Eulitz, M., Weiss, D., and Solomon, A., 1990, Immunoglobulin heavy-chain-associated amyloidosis, Proc. Natl. Acad. Sci. USA 87: 6542–6546.PubMedGoogle Scholar
  60. Eyanson, S., and Benson, M. D., 1983, Erosive arthritis in hereditary amyloidosis, Arthritis Rheum. 26: 1145–1149.PubMedGoogle Scholar
  61. Falk, R. H., Lee, V. W., Rubinow, A., Skinner, M., and Cohen, A. S., 1984, Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis, Am. J. Cardiol. 54: 1160–1161.Google Scholar
  62. Ferguson, R. N., Edelhoch, H., Saroff, H. A., Robbins, J., and Cahnmann, H. J., 1975, Negative cooperativity in the binding of thyroxine to human serum prealbumin, Biochemistry 14: 282–289.PubMedGoogle Scholar
  63. Ferlini, A., Romeo, G., Tassinari, C. A., Saraiva, M. J. M., Costa, P. P., and Salvi, F., 1988, Discrimination of peripheral polyneuropathies caused by TTR variant or diabetes in the same pedigree through protein studies, Adv. Neurol. 48: 201–208.PubMedGoogle Scholar
  64. Filipowicz-Sosanowska, A. M., Roztropowicz-Denisiewicz, K., Rosenthal, C. J., and Baum, J., 1978, The amyloidosis of juvenile rheumatoid arthritis. Comparative studies in Polish and American children, Arthritis Rheum. 21: 699–703.Google Scholar
  65. Fitch, N. J. S., Akbari, M. T., Sheppard, M. C., and Ramsden, D. B., 1990, Serine- for-glycine substitution at position 6 in an inherited, non-lethal transthyretin variant with increased thyroxine-binding affinity, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 189.Google Scholar
  66. Folstein, M. F., and Powell, D., 1989, In search of the Alzheimer’s disease gene, in: Familial Alzheimer’s Disease: Molecular Genetics and Clinical Perspectives ( G. D. Miner, R. Richter, J. P. Blass, J. L. Valentine, and L. A. Miner, eds.) Marcel Dekker, New York, pp. 3–13.Google Scholar
  67. Frederiksen, T., Gotzsche, H., and Harboe, N., 1962, Familial primary amyloidosis with severe amyloid heart disease, Am. J. Med. 33: 329–348.Google Scholar
  68. Fujihara, S., Shimode, K., Nakamura, M., Kobayashi, S., Tsunematsu, T., Palsdottir, A., and Jensson, O., 1990, Cerebral amyloid angiopathy associated with cerebral hemorrhage and related to the deposition of cystatin-C, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 108.Google Scholar
  69. Fung, W. P., Thomas, T., Dickson, P. W., Aldred, A. R., Milland, J., Dziadek, M., Power, B., Hudson, P., and Schreiber, G., 1988, Structure and expression of the rat transthyretin (prealbumin) gene, J. Biol. Chem. 263: 480–488.PubMedGoogle Scholar
  70. Furuya, H., Yoshioka, K., Sasaki, H., Sakaki, Y., Nakazato, M., Matsuo, H., Nakadai, A., and Ikeda, S. I., 1987, Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs, J. Clin. Invest. 80: 1706–1711.PubMedGoogle Scholar
  71. Furuya, H., Sasaki, H., Goto, I., Wong, C. W., Glenner, G. G., and Sakaki, Y., 1988, Amyloid ß-protein gene duplication is not common in Alzheimer’s disease: Analysis by polymorphic restriction fragments, Biochem. Biophys. Res. Commun. 150: 75–81.PubMedGoogle Scholar
  72. Gafni, J., Ravid, M., and Sohar, E., 1968, The role of amyloidosis in familial Mediterranean fever: A population study, Isr. J. Med. Sci. 4: 995–999.PubMedGoogle Scholar
  73. Gafni, J., Fischel, B., Reif, R., Yaron, M., and Pras, M., 1985, Amyloidotic polyneuropathy in a Jewish family. Evidence for the genetic heterogeneity of the lower limb familial amyloidotic neuropathies, Q. J. Med. 55: 33–43.PubMedGoogle Scholar
  74. Gagel, R. F., Levy, M. L., Donovan, D. T., Alford, B. R., Wheeler, T., and Tschen, J. A., 1989, Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis, Ann. Intern. Med. 111: 802–806.PubMedGoogle Scholar
  75. Gallo, G., Picken, M., and Buxbaum, J., 1988, Deposits in monoclonal immunoglobulin deposition disease lack amyloid P-component, Mod. Pathol. 1: 453–456.PubMedGoogle Scholar
  76. Garrod, A., 1928, The lessons of rare maladies, Lancet 1: 1055–1059.Google Scholar
  77. Gertz, M. A., Petitt, R. M., Pencault, J., and Kyle, R. A., 1987, Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis, Mayo Clin. Proc. 62: 1095–1100.PubMedGoogle Scholar
  78. Ghiso, J., Jensson, O., and Frangione, B., 1986, Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C), Proc. Natl. Acad. Sci. USA 83: 2974–2978.PubMedGoogle Scholar
  79. Glenner, G. G., 1980, Amyloid deposits and amyloidosis. The ß-fibrilloses (first of two parts), N. Engl. J. Med. 302: 1283–1292.PubMedGoogle Scholar
  80. Glenner, G. G., and Murphy, M. A., 1989, Amyloidosis of the nervous system, J. Neurol. Sci. 94: 1–28.PubMedGoogle Scholar
  81. Glenner, G. L., and Wong, C. W., 1984, Alzheimers disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun. 120: 885–890.PubMedGoogle Scholar
  82. Glenner, G. G., Harada, M., and Isersky, C., 1972, The purification of amyloid fibril proteins, Prep. Biochem. 2: 39–51.PubMedGoogle Scholar
  83. Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., and Gajdusek, D. C., 1987, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease, Science 235: 877–884.PubMedGoogle Scholar
  84. Gorevic, P. D., Greenwald, M., Frangione, B., Pras, M., and Franklin, E. C., 1977, The amino acid sequence of duck amyloid A (AA) protein, J. Immunol. 118: 1113–1118.PubMedGoogle Scholar
  85. Gorevic, P. D., Rodrigues, M. M., Spencer, W. H., Munoz, P. C., Allen, A. W., and Verne, A. Z., 1987, Prealbumin. A major constituent of vitreous amyloid, Ophthalmology 94: 792–798.PubMedGoogle Scholar
  86. Gorevic, P. D., Prelli, F. C., Wright, J., Pras, M., and Frangione, B., 1989, Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: Immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy, J. Clin. Invest. 83: 836–843.PubMedGoogle Scholar
  87. Gorevic, P. D., Rodrigues, M., Munoz, P. C., Haltia, M., Ghiso, J., and Frangione, B., 1990, Shared gelsolin antigenicity between familial amyloidosis Finnish type (FAF) and one form of familial lattice corneal dystrophy (LCD) with polyneuropathy from the United States, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 107.Google Scholar
  88. Grubb, A., and Lofberg, H., 1985, Human gamma-trace: Structure, function and clinical use of concentration measurements, Scand. J. Clin. Lab. Invest. 45: 7–13.Google Scholar
  89. Grubb, A., Jensson, O., Gudmundsson, G., Arnason, A., Lofberg, H., and Malm, J., 1984, Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis, N. Engl. J. Med. 311: 1547–1549.PubMedGoogle Scholar
  90. Gudmundsson, G., Hallgrimsson, J., Jonasson, T. A., and Bjarnason, O., 1972, Hereditary cerebral hemorrhage with amyloidosis, Brain 95: 387–404.PubMedGoogle Scholar
  91. Haan, J., and Roos, R. A. C., 1990, Dementia in hereditary cerebral amyloidosis, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 137.Google Scholar
  92. Haltia, M., Prelli, F., Ghiso, J., Kiuru, S., Somer, H., Palo, J., and Frangione, B., 1990, Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein, Biochem. Biophys. Res. Commun. 167: 927–932.PubMedGoogle Scholar
  93. Hamilton, J. A., Steinrauf, L. K., Hariharan, M., Liepnieks, J., Benson, M. D., Holmgren, G., Sandgren, O., and Steen, L., 1990, X-ray crystal structure of the Met-30 variant of human serum prealbumin (transthyretin), VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 128.Google Scholar
  94. Hanyu, N., Ikeda, S., Nakadai, A., Yanagisawa, N., and Powell, H. C., 1989, Peripheral nerve pathological findings in familial amyloid polyneuropathy: A correlative study of proximal sciatic nerve and sural nerve lesions, Ann. Neurol. 25: 340–350.PubMedGoogle Scholar
  95. Harats, N., Kluve-Beckerman, B., Skinner, M., Passo, M., Quinn, L., and Benson, M. D., 1989, Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis, Arthritis Rheum. 32: 1325–1327.PubMedGoogle Scholar
  96. Hawkins, P. N., Cavender, J. P., and Pepys, M. B., 1990, Evaluation of systemic amyloidosis by scintigraphy with 125I-labeled serum amyloid P component, N. Engl. J. Med. 323: 508–513.PubMedGoogle Scholar
  97. Hazenberg, B. C. P., Marrink, J., Nakazato, M., de Jong, R., Janssen, S., and van Rijswijk, M. H., 1990, Two Dutch families with FAP type I. Clinical data and biochemical characterization of the TTR variant, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3:188.Google Scholar
  98. Heller, H., Sohar, E., and Sherf, L., 1958, Familial Mediterranean fever, Arch. Intern. Med. 102: 50–71.Google Scholar
  99. Herbert, J., Wilcox, J. N., Pham, K. C., Fremeau, R. T., Zaviani, M., Dwork, A., Soprano, D., Makover, A., Goodman, D. S., Zimmerman, E. Z., Roberts, J. L., and Schon, E. A., 1986, Transthyretin: A choroid plexus-specific transport protein in human brain, Neurology 36: 900–911.PubMedGoogle Scholar
  100. Hesse, A., Altland, R. P., Linke, A., Steinmetz, A., and Maisch, B., 1990, A new transthyretin genetic variant in a family with cardiac amyloidosis, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 126.Google Scholar
  101. Hind, C. R. K., 1989, Amyloidosis and Amyloid P Component, Wiley, New York.Google Scholar
  102. Hirschhorn, R., Tzall, S., and Ellenbogen, A., 1990, Hot spot mutations in adenosine deaminase deficiency, Proc. Natl. Acad. Sci. USA 87: 6171–6175.PubMedGoogle Scholar
  103. Hodkinson, H. M., and Pomerance, A., 1977, The clinical significance of senile cardiac amyloidosis: A prospective clinico-pathological study, Q. J. Med. XLVI: 381–387.Google Scholar
  104. Holmgren, G., Haettner, E., Nordenson, I., Sandgren, O., Steen, L., and Lundgren, E., 1988, Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathy, Clin. Genet. 34: 333–338.PubMedGoogle Scholar
  105. Holmgren, G., Drugge, U., Haettner, E., Lundgren, E., Sandgren, O., and Steen, L., 1990, Four Swedish cases with homozygosity for the FAP-Met30-gene, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 193.Google Scholar
  106. Holt, I. J., Harding, A. E., Middleton, L., Chrysostomou, G., Said, G., King, R. H. M., and Thomas, P. K., 1989, Molecular genetics of amyloid neuropathy in Europe, Lancet 1: 524–526.PubMedGoogle Scholar
  107. Hongo, M., and Ikeda, S. I., 1986, Echocardiographic assessment of the evolution of amyloid heart disease: A study with familial amyloid polyneuropathy, Circulation 73: 249–256.PubMedGoogle Scholar
  108. Hongo, M., Hirayama, J., Fujii, T., Yamada, H., Okubo, S., Kusama, S., and Ikeda, S. I., 1987, Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: A study with familial amyloid polyneuropathy, Am. Heart J. 113: 654–662.PubMedGoogle Scholar
  109. Ikeda, S., Hanyu, N., Hongo, M., Yoshioka, J., Oguchi, H., Yanagiawa, N., Kobayashi, T., Tsukagoshi, H., Ito, N., and Yokota, T., 1987, Hereditary generalised amyloidosis with polyneuropathy. Clinico-pathological study of 65 Japanese patients, Brain 110: 315–337.PubMedGoogle Scholar
  110. Ikegawa, S., Araki, S., Ando, Y., Yi, S., and Miyazaki, A., 1990a, Réévaluation of 134 patients with familial amyloidotic polyneuropathy (FAP) type I in Japan, Kumamoto focus, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 129.Google Scholar
  111. Ikegawa, S., Tanaka, Y., Fukushima, T., Yi, S., Ikeda, T., Ando, Y., Miyazaki, A., and Araki, S., 1990b, Therapeutic efficacy of plasma exchange in the treatment of familial amyloidotic polyneuropathy (type I) in Japan, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 201.Google Scholar
  112. Jacobson, D. R., Santiago-Schwarz, R., Rosenthal, C. J., and Buxbaum, J. N., 1987, Identification of new restriction fragment length polymorphisms associated with familial amyloidotic polyneuropathy, Clin. Res. 35: 594a.Google Scholar
  113. Jacobson, D. R., Santiago-Schwarz, R., and Buxbaum, J. N., 1988, Restriction fragment analysis confirms the position 33 mutation in transthyretin from an Israeli patient (SKO) with familial amyloidotic polyneuropathy, Biochem. Biophys. Res. Commun. 153: 198–202.PubMedGoogle Scholar
  114. Jacobson, D. R., Gorevic, P. D., and Buxbaum, J. N., 1990ût, A homozygous transthyretin variant associated with senile systemic amyloidosis: Evidence for a late-onset disease of genetic etiology, Am. J. Hum. Genet. 47: 127–136.Google Scholar
  115. Jacobson, D. R., Reveille, J. D., and Buxbaum, J. N., 1990b, Frequency of the position 122 variant transthyretin gene in Blacks without amyloidosis, VI Int. Symp. Amyloidosis Progr. Abstr. 1990:57.Google Scholar
  116. Jacobsson, B., Collins, V. P., Grimelius, L., Pettersson, T., Sandstedt, B., and Carlstrom, A., 1989, Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets, J. Histochem. Cytochem. 37: 31–37.PubMedGoogle Scholar
  117. Jensson, O., Gudmundsson, G., Arnason, A., Blondal, H., Petursdottir, I., Thorsteinsson, L., Grubb, A., Lôfberg, H., Cohen, D., and Frangione, B., 1987, Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage, Acta Neurol. Scand. 76: 102–114.PubMedGoogle Scholar
  118. Johansson, B., and Wester mark, P., 1990, The relation of atrial natriuretic factor to isolated atrial amyloid, Exp. Mol. Pathol. 52: 266–278.PubMedGoogle Scholar
  119. Johnson, K. H., O’Brien, T. D., Betsholtz, C., and Westermark, P., 1989, Islet amyloid, islet amyloid polypeptide, and diabetes mellitus, N. Engl. J. Med. 321: 513–518.PubMedGoogle Scholar
  120. Jones, L. A., Harding, J. A., Cohen, A. S., and Skinner, M., 1990, New USA family has apolipoprotein A1 (Arg 26) variant, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 104.Google Scholar
  121. Jones, R. S., and Frazier, D. B., 1950, Primary cardiovascular amyloidosis. Its clinical manifestations, pathology, and histogenesis, Arch. Pathol. 50: 366–384.Google Scholar
  122. Josselson, A. J., Pruitt, R. D., and Edwards, I. E., 1952, Amyloid localized to the heart. Analysis of twenty-nine cases, Arch. Pathol. 54: 359–367.Google Scholar
  123. Kametani, F., Tonoike, H., Hoshi, A., Shinoda, T., and Shozo, K., 1984, A variant prealbumin-related low molecular weight amyloid fibril protein in familial amyloid polyneuropathy of Japanese origin, Biochem. Biophys. Res. Commun. 125: 622–628.PubMedGoogle Scholar
  124. Kark, J. D., Kedem, R., and Rwach, M., 1986, Medical examination of Israeli 17 year olds before military service as a national resource for health information, Isr. J. Med. Sci. 22: 318–325.PubMedGoogle Scholar
  125. Kato, M., Soprano, D. R., Makover, A., Kato, K., Herbert, H., and Goodman, D. S., 1986, Localization of immunoreactive transthyretin (prealbumin) and of transthyretin mRNA in fetal and adult rat brain, Differentiation 31: 228 - 235.PubMedGoogle Scholar
  126. King, L. S., 1948, Atypical amyloid disease, with observations on a new silver stain for amyloid, Am. J. Pathol 24: 1095–1115.PubMedGoogle Scholar
  127. Kinowhita, O., Hongo, M., Yamada, H., Misawa, T., Kono, J., Okubo, S., and Ikeda, S., 1989, Impaired left ventricular diastolic filling in patients with familial amyloid polyneuropathy: A pulsed Doppler echocardiographic study, Br. Heart J. 61: 198–203.Google Scholar
  128. Kiuru, S., Seppalainen, A. M., Somer, H., Haltia, M., Valle, O., and Palo, J., 1990, Familial amyloid polyneuropathy type IV (Finnish type): A clinical neurological and neurophy- siological study, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 105.Google Scholar
  129. Kluve-Beckerman, B., and Benson, M. D., 1990, The human SAA gene family, VIInt. Symp. Amyloidosis Progr. Abstr. 1990: 41.Google Scholar
  130. Kluve-Beckerman, B., Naylor, S. L., Marshall, A., Gardner, J. C., Shows, T. B., and Benson, M. D., 1986, Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms, Biochem. Biophys. Res. Commun. 137: 1196–1204.PubMedGoogle Scholar
  131. Kluve-Beckerman, B., Dwulet, F. E., and Benson, M. D., 1988, Human serum amyloid A. 3 hepatic mRNA’s and the corresponding proteins in one person, J. Clin. Invest. 82: 1670–1675.PubMedGoogle Scholar
  132. Kobayashi, H., and Hashimoto, K., 1983, Amyloidogenesis in organ-limited cutaneous amyloidosis: An antigenic identity between epidermal keratin and skin amyloid, J. Invest. Dermatol. 80: 66–72.PubMedGoogle Scholar
  133. Kono, J., Hongo, M., Okubo, S., Yamada, H., Misawa, T., and Kinoshita, O., 1989, Left ventricular systolic and diastolic time intervals in familial amyloid polyneuropathy, Jpn. Circ. J. 53: 291–297.PubMedGoogle Scholar
  134. Kyle, R. A., and Gertz, M. A., 1990a, Systemic amyloidosis, CRC Crit. Rev. Oncol. Hematol. 10: 49–49.Google Scholar
  135. Kyle, R. A., and Gertz, M. A., 19906, Cardiac amyloidosis, Int. J. Cardiol. 28: 139–141.Google Scholar
  136. Lanham, J. G., Meltzer, M. L., De Beer, F. C., Hughes, G. R. V., and Pepys, M. B., 1982, Familial amyloidosis of Ostertag, Q. J. Med. LI: 25–32.Google Scholar
  137. Lavie, G., Zucker-Franklin, D., and Franklin, E. C., 1978, Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes, J. Exp. Med. 148: 1020–1031.PubMedGoogle Scholar
  138. Lee, H. Y., and Kaufmann, W., 1957, Cardiac amyloidosis in the aged, Arch. Pathol. 64: 494–500.Google Scholar
  139. Levin, M., Franklin, E. C., Frangione, B., and Pras, M., 1972, The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils, J. Clin. Invest. 51: 2773–2776.PubMedGoogle Scholar
  140. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., Van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., and Frangione, B., 1990, Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science 248: 1124–1126.PubMedGoogle Scholar
  141. Lie, J. T., and Hammond, H., 1988, Pathology of the senescent heart: Anatomic observations on 237 autopsy studies of patients 90 to 105 years old, Mayo Clin. Proc. 63: 552–564.PubMedGoogle Scholar
  142. Luis, M. L. S., Galvao, M., Carvalho, M., Sousa, G., Alves, M. M., and Serrao, R., 1990, Plasma exchange on the treatment of familial amyloid polyneuropathy (FAP)-Portuguese type, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 201.Google Scholar
  143. Mahloudji, M., Teasdall, R. D., Adamkiewicz, J. J., Hartmann, W. H., Lambird, P. A., and McKusick, V. A., 1969, The genetic amyloidoses. With particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type), Medicine 48: 1–37.PubMedGoogle Scholar
  144. Martone, R. L., Herbert, J., Dwork, A., and Schon, E. A., 1988, Transthyretin is synthesized in the mammalian eye, Biochem. Biophys. Res. Commun. 151: 905–912.PubMedGoogle Scholar
  145. Mathew, C. G., Chin, K. S., and Easton, D. F., 1987, A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10, Nature 328: 527–528.PubMedGoogle Scholar
  146. Matzner, Y., and Brzezinski, A., 1984, C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever, N. Engl. J. Med. 311: 287–290.PubMedGoogle Scholar
  147. Matzner, Y., Ayesh, S. K., Hochner-Celniker, D., Ackerman, Z., and Feme, M., 1990, Proposed mechanism of the inflammatory attacks in familial Mediterranean fever, Ann. Intern. Med. 150: 1289–1291.Google Scholar
  148. Maury, C. P. J., Alii, K., and Baumann, M., 1990a, Finnish hereditary amyloidosis: Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline, FEBS Lett. 260: 85–87.PubMedGoogle Scholar
  149. Maury, C. P. J., 19906, Complete primary structure of amyloid fibril protein in Finnish hereditary amyloidosis: Identification of a new type of amyloid protein derived from variant gelsolin, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 104.Google Scholar
  150. Meretoja, J., 1969, Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms, Ann. Clin. Res. 1: 314–324.PubMedGoogle Scholar
  151. Meretoja, J., Hollmen, T., Meretoja, T., and Penttinen, R., 1978, Partial characterization of amyloid proteins in inherited amyloidosis with lattice corneal dystrophy and in secondary amyloidosis, Medicine 56: 17–22.Google Scholar
  152. Meyerholl, J., 1980, Familial Mediterranean fever: Report of a large family, review of the literature, and discussion of the frequency of amyloidosis, Medicine 59: 66–77.Google Scholar
  153. Mita, S., Maeda, S., Shimada, K., and Araki, S., 1984, Cloning and sequence analysis of cDNA for human prealbumin, Biochem. Biophys. Res. Commun. 124: 558–564.PubMedGoogle Scholar
  154. Mornaghi, R., Rubinstein, P., and Franklin, E. C., 1982, Familial renal amyloidosis: Case reports and genetic studies, Am. J. Med. 73: 609–614.PubMedGoogle Scholar
  155. Muckle, T. J., and Wells, M. V., 1962, Urticaria deafness and amyloidosis: A new hereditary syndrome, Q. J. Med. 31: 235–248.PubMedGoogle Scholar
  156. Miiller-Hill, B., and Beyreuther, K., 1990, Molecular biology of Alzheimer’s disease, Annu. Rev. Biochem. 58: 287–307.Google Scholar
  157. Munar-Ques, M., Costa, P. P., and Saraiva, M. J. M., 1990, The Majorcan focus of familial amyloidotic polyneruopathy, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 30: 187.Google Scholar
  158. Murakami, T., Ohnishi, S., Nishiguchi, S., Maeda, S., Araki, S., and Shimada, K., 1988, Acute-phase response of mRNAs for serum amyloid P component, C-reactive protein and prealbumin (transthyretin) in mouse liver, Biochem. Biophys. Res. Commun. 155: 554–560.PubMedGoogle Scholar
  159. Murdoch, G. H., Manuelidis, L., Kim, J. H., and Manuelidis, E. E., 1988, ß-Amyloid gene dosage in Alzheimer’s disease, Nucleic Acids Res. 16: 357.Google Scholar
  160. Mutru, O., Laakso, M., Isomaki, H., and Koota, K., 1985, Ten year mortality and causes of death in patients with rheumatoid arthritis, Br. Med. J. 290: 1797–1799.Google Scholar
  161. Nakazato, M., Kangawa, K., Minamino, N., Tawara, S., Matsuo, H., and Araki, S., 1984, Revised analysis of amino acid replacement in a prealbumin variant (SKO-III) associated with familial amyloidotic polyneuropathy of Jewish origin, Biochem. Biophys. Res. Commun. 123: 921–928.PubMedGoogle Scholar
  162. Nakazato, M., Kurihara, T., Matsukura, S., Kangawa, K., and Matsuo, H., 1986, Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy before clinical onset, J. Clin. Invest. 77: 1699–1703.PubMedGoogle Scholar
  163. Nakazato, M., Tanaka, M., Yamamura, Y., Kurihara, T., Matsukura, S., Kangawa, K., and Matsuo, H., 1987, Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy, Arch. Neurol. 44: 1275–1278.PubMedGoogle Scholar
  164. Nichols, W. C., and Benson, M. D., 1990, Hereditary amyloidosis: Detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences, Clin. Genet. 37: 44–53.PubMedGoogle Scholar
  165. Nichols, W. C., Dwulet, F. E., Liepnieks, J., and Benson, M. D., 1988, Variant apolipoprotein AI as a major constituent of human hereditary amyloid, Biochem. Biophys. Res. Commun. 156: 762–768.PubMedGoogle Scholar
  166. Nichols, W. C., Liepnieks, J. J., McKusick, V. A., and Benson, M. D., 1989, Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification, Genomics 5: 535–540.PubMedGoogle Scholar
  167. Nichols, W. C., Snyder, E. L., Liepnieks, J. J., and Benson, M. D., 1990, Senile cardiac amyloidosis is a hereditary disease, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 190.Google Scholar
  168. Niklasson, U., Olofsson, B. O., and Bjerle, P., 1989, Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability, Acta Neurol. Scand. 79: 182–187.PubMedGoogle Scholar
  169. Nilsson, S. E., and Floderus, S., 1964, Nine cases of hereditary and non-hereditary periodic diseases, Acta Med. Scand. 175: 341–346.PubMedGoogle Scholar
  170. Nippoldt, T. B., Edwards, W. D., Holmes, D. R., Reeder, G. S., Gartzler, G. O., and Smith, H. C., 1982, Right ventricular endomyocardial biopsy. Clinicopathologic correlates in 100 consecutive patients, Mayo Clin. Proc. 57: 407–418.PubMedGoogle Scholar
  171. Nordlie, M., Sletten, K., Husby, G., and Ranlov, P. J., 1988, A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin, Scand. J. Immunol. 27: 11–122.Google Scholar
  172. Noren, P., Westermark, P., Cornwell, G. G., and Murdoch, W., 1983, Immunofluorescence and histochemical studies of localized cutaneous amyloidosis, Br. J. Dermatol. 108: 277–285.PubMedGoogle Scholar
  173. Olofsson, B., and Eriksson, P., 1986, Heart valve involvement in familial amyloidosis with polyneuropathy, Path. Res. Pract. 181: 563–567.PubMedGoogle Scholar
  174. Olson, L. J., Gertz, M. A., Edwards, W. D., Chin-Yang, L., Pellikka, P. A., Holmes, D. R., Tajik, A. J., and Kyle, R. A., 1987, Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry, N. Engl. J. Med. 317: 738–742.PubMedGoogle Scholar
  175. Oltersdorf, T., Fritz, L. C., Schenk, D. B., Lieberburg, I., Johnson-Wood, K. L., Beattie, E. C., Ward, P. J., Blacher, R. W., Dovey, H. F., and Sinha, S., 1989, The secreted form of the Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin-II, Nature 341: 144–147.PubMedGoogle Scholar
  176. Ozedemir, A., and Sokman, C., 1969, Familial Mediterranean fever among the Turkish people, Am. J. Gastroenterol. 51: 311–316.Google Scholar
  177. Ozer, F. L., Kaplaman, E., and Zeleli, S., 1971, Familial Mediterranean fever in Turkey: A report of 20 cases, Am. J. Med. 50: 336–339.PubMedGoogle Scholar
  178. Palsdottir, A., Thorsteinsson, L., Olafsson, I., Abrahamson, M., Arnason, A., and Grubb, A., 1988, Mutation in cystatin C gene causes hereditary brain haemorrhage, Lancet 2: 603–604.PubMedGoogle Scholar
  179. Parmelee, D. C., Titani, K., Ericsson, L. H., Eriksen, N., Benditt, E. P., and Walsh, K. A., 1982, Amino acid sequence of amyloid-related apoprotein (apoSAA!) from human high-density lipoprotein, Biochemistry 21: 3298–3303.PubMedGoogle Scholar
  180. Partington, W., and Prentice, R. S. A., 1989, K-linked cutaneous amyloidosis: Further clinical and pathological observations, Am. J. Med. Genet. 32: 115–119.PubMedGoogle Scholar
  181. Patterson, D., Gardiner, K., Kao, F.-T., Tanzi, R., Watkins, P., and Gusella, J. F., 1988, Mapping of the gene encoding the ß-amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21, Proc. Natl. Acad. Sci. USA 85: 8266–8270.PubMedGoogle Scholar
  182. Pitkanen, P., Westermark, P., and Cornwell, G. G., III, 1984, Senile systemic amyloidosis, Am. J. Pathol. 117: 391–399.PubMedGoogle Scholar
  183. Podlisny, M. B., Lee, G., and Selkoe, D. J., 1987, Gene dosage of the amyloid ß precursor protein in Alzheimer’s disease, Science 238: 669–671.PubMedGoogle Scholar
  184. Pomerance, A., 1965, Senile cardiac amyloidosis, Br. Heart J. 27: 711–718.PubMedGoogle Scholar
  185. Pomerance, A., 1966, The pathology of senile cardiac amyloidosis, J. Pathol. Bacteriol. 91: 357–367.PubMedGoogle Scholar
  186. Pras, M., Schubert, M., Zucker-Franklin, D., Rimon, A., and Franklin, E. C., 1968, The characterization of soluble amyloid prepared in water, J. Clin. Invest. 47: 924–933.PubMedGoogle Scholar
  187. Pras, M., Bronshpigel, N., Zemer, D., and Gafni, J., 1982, Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups, Johns Hopkins Med. J. 150: 22–26.PubMedGoogle Scholar
  188. Pras, M., Prelli, F., Franklin, E. C., and Frangione, B., 1983, Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin, Proc. Natl. Acad. Sci. USA 80: 539–542.PubMedGoogle Scholar
  189. Ranlov, I., Alves, I., Ranlov, P. J., Husby, G., Costa, P. P., and Saraiva, M. J. M., 1990, Identification of the mutant TTR-Met-111 variant in serum from patients and presumed carriers of familial amyloid cardiomyopathy (FAC) of Danish origin, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 133.Google Scholar
  190. Ranstroem, S., 1951, Myocardial amyloidosis, Acta Pathol. Microbiol. Scand. 23: 302–308.Google Scholar
  191. Reich, C. B., and Franklin, E. C., 1970, Familial Mediterranean fever in an Italian family, Arch. Intern. Med. 125: 337–340.PubMedGoogle Scholar
  192. Reimann, H. A., Moadie, J., Senurdjian, S., and Sahyoun, P. F., 1954, Periodic peritonitis — heredity and pathology: Report of 72 cases, J. Am. Med. Assoc. 154: 1254–1259.PubMedGoogle Scholar
  193. Roos, R. A. C., Haan, J., Van Duinen, S. G., and Bots, G. T. A. M., 1990, Neuropathological changes in hereditary cerebral hemorrhage with amyloidosis — Dutch type, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 136.Google Scholar
  194. Rukavina, J. G., Block, W. D., Jackson, C. E., Falls, H. F., Cary, J. H., and Curtis, A. C., 1956, Primary systemic amyloidosis: A review and an experimental genetic and clinical study of 29 cases with particular emphasis on the familial form, Medicine 359: 239–334.Google Scholar
  195. Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., and Masters, C. L., 1989, Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease, N. Engl. J. Med. 320: 1446–1452.PubMedGoogle Scholar
  196. Saad, M. F., Ordonez, N. G., Rashid, R. K., Guido, J. J., Hill, C. S., Hickey, R. C., and Samaan, N. A., 1984, Medullary carcinoma of the thyroid: A study of the clinical features and prognostic factors in 161 patients, Medicine 63: 319–342.PubMedGoogle Scholar
  197. Sakaki, Y., Sasaki, H., Yoshioka, K., and Furuya, H., 1989, Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease, Clin. Chim. Acta 185: 291–298.PubMedGoogle Scholar
  198. Salvi, F., Ferlini, A., Plasmati, R., Costa, P. P., Rubboli, G., Saraiva, M. J. M., Michelucci, R., Forti, A., and Tassinari, C. A., 1990a, Clinical characterization of a new TTR variant in an Italian family: TTR Ala 49, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 134.Google Scholar
  199. Salvi, F., Montagna, P., Plasmati, R., Rubboli, G., Cirignotta, F., Veilleux, M., Lugaresi, E., and Tassinari, C. A., 19906, Restless legs syndrome and nocturnal myoclonus: Initial clinical manifestation of familial amyloid polyneuropathy, J. Neurol. Neurosurg. Pyschiatry 53: 522–525.Google Scholar
  200. Sandgren, O., Holmgren, G., Lundgren, E., and Steen, L., 1988, Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis, Arch. Ophthalmol. 106: 790–792.PubMedGoogle Scholar
  201. Saraiva, M. J. M., Costa, P. P., Birken, S., and Goodman, D. S., 1983, Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy, Trans. Assoc. Am. Physicians 96: 261–270.PubMedGoogle Scholar
  202. Saraiva, M. J. M., Birken, S., Costa, P. P., and Goodman, D. S., 1984, Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: Definition of molecular abnormality in transthyretin (prealbumin), J. Clin. Invest. 74: 104–119.PubMedGoogle Scholar
  203. Saraiva, M. J. M., Costa, P. P., and Goodman, D. S., 1985, Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant, J. Clin. Invest. 76: 2171–2177.PubMedGoogle Scholar
  204. Saraiva, M. J. M., Costa, P. P., and Goodman, D. S., 1986a, Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy, Neurology 36: 1413–1417.PubMedGoogle Scholar
  205. Saraiva, M. J. M., Sherman, W., and Goodman, D. S., 1986ft, Presence of a plasma transthyretin (prealbumin) variant in familial amyloidotic polyneuropathy in a kindred of Greek origin, J. Lab. Clin. Med. 108: 17–22.Google Scholar
  206. Saraiva, M. J. M., Almeida, M. R., Costa, P. P., Altland, K., and Gawinowicz, M. A., 1990a, Non pathogenic TTR mutations, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 188.Google Scholar
  207. Saraiva, M. J. M., Sherman, W., Marboe, C., Figueira, A., Costa, P., De Freitas, A. F., and Gawinowicz, M. A., 1990ft, Cardiac amyloidosis: Report of a patient heterozygous for the transthyretin-isoleucine 122 variant, Scand. J. Immunol. 32: 341–346.Google Scholar
  208. Saraiva, M. J. M., Almeida, M. R., Costa, P. P., Salvi, F., Ferlini, A., Altland, K., Sakaki, Y., Sherman, W., and Gawinowicz, M. A., 1990c, New transthyretin mutations associated with neuropathy and/or cardiomyopathy, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 189.Google Scholar
  209. Sasaki, H., Sakaki, Y., Matsuo, H., Goto, I., Kuroiwa, Y., Sahashi, I., Takahashi, A., Shinoda, T., Isobe, T., and Yakagi, Y., 1984, Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques, Biochem. Biophys. Res. Commun. 125: 636–642.PubMedGoogle Scholar
  210. Sasaki, H., Yoshioka, N., Yasuyuki, T., and Sakaki, Y., 1985, Structure of the chromosomal gene for human serum prealbumin, Gene 37: 191–197.PubMedGoogle Scholar
  211. Scelsi, R., Verri, A. P., Bono, G., and Marbini, A., 1989, Familial amyloid polyneuropathy: Report of an autopsy case with neuropathy, vitreous opacities and polycystic kidney, Eur. Neurol. 29: 27–32.PubMedGoogle Scholar
  212. Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Moore, D. K., Boehnke, M., Bryant, E. M., Lampe, T. H„ Nochlin, D., Sumi, S. M., Deeb, S. S., Beyreuther, K., and Martin, G. M., 1987, Absence of linkage of chromosome 21q21 markers to familial Alzheimer’s disease, Science 241: 1507–1510.Google Scholar
  213. Schwabe, A. D., and Peters, R. S., 1974, Familial Mediterranean fever in Armenians: Analysis of 100 cases, Medicine 53: 453–462.PubMedGoogle Scholar
  214. Selkoe, D. J., 1990, Deciphering Alzheimer’s disease: The amyloid precursor protein yields new clues, Science 248: 1058–1060.PubMedGoogle Scholar
  215. Shimada, K., Maeda, S., Murakami, T., Nishiguchi, S., Tashiro, F., Yi, S., Wakasugi, S., Takahashi, K., and Yamamura, K., 1989, Transgenic mouse model of familial amyloidotic polyneuropathy, Mol. Biol Med. 6: 333–343.PubMedGoogle Scholar
  216. Shiroo, M., Kawahara, E., Nakanishi, I., and Migita, S., 1988, SAA2 deposition in the spleen of the mouse, Proc. V Int. Symp. Amyloidosis 1988: 63–68.Google Scholar
  217. Salvi, F., Plasmati, R., Rubboli, G., Michelucci, R., Forti, A., Ferlini, A., Saraiva, M. J. M., Costa, P. P., and Tassinari, C. A., 1990c, Familial amyloidotic polyneuropathy in Italy, Proc. 1st Int. Symp. Familial Amyloidotic Polyneuropathy 3: 187Google Scholar
  218. Simpson, N. E., Kidd, K. K., and Goodfellow, P. J., 1987, Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage, Nature 328: 528–530.PubMedGoogle Scholar
  219. Sisodia, S. S., Koo, E. H., Beyreuther, K., Ventarbeck, K. A., and Price, D. L., 1990, Evidence that ß-amyloid protein in Alzheimer’s disease is not derived by normal processing, Science 248: 492–495.PubMedGoogle Scholar
  220. Skare, J. C., Saraiva, M. J. M., Alves, I. L., Skare, I. B., Milunsky, A., Cohen, A. S., and Skinner, M., 1989, A new mutation causing familial amyloidotic polyneuropathy, Biochem. Biophys. Res. Commun. 164: 1240–1246.PubMedGoogle Scholar
  221. Skare, J. C., Jones, L. A., Cohen, A. S., Milunsky, A., and Skinner, M., 1990, Asn 90 is the variant TTR in an Italian FAP kinship, VI Int. Symp. Amyloidosis Progr. Abstr. 1990:56.Google Scholar
  222. Skinner, M., and Cohen, A. S., 1981, The prealbumin nature of the amyloid protein in familial amyloid polyneuropathy (FAP) — Swedish variety, Biochem. Biophys. Res. Commun. 99: 1326–1332.PubMedGoogle Scholar
  223. Skinner, M., Connors, L. H., Rubinow, A., Libbey, C., Sipe, J. D., and Cohen, A. S., 1985, Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives, Am. J. Med. Sci. 289: 17–21.PubMedGoogle Scholar
  224. Skinner, M., Pinnette, A., and Travis, W. D., 1988, Amino acid seuqence composition of AA amyloid fibrils in cystic fibrosis, in: Amyloid and Amyloidosis (T. Isobe, S. Araki, F. Uchino, S. Kito, and E. Tsubura, eds.), Plenum Press, New York, pp. 205–209.Google Scholar
  225. Skinner, M., Skare, J. C., Yasici, H., Erken, E., Milunsky, A., and Cohen, A. S., 1990, First Turkish FAP has homozygous Met 30 TTR, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 122.Google Scholar
  226. Sletten, K., and Husby, G., 1974, The complete amino acid sequence of non-immunoglobulin amyloid fibril AS in theumatoid arthritis, Eur. J. Biochem. 41: 117–125.PubMedGoogle Scholar
  227. Sletten, K., and Westermark, P., 1990, Characterization of molecular forms of calcitonin in amyloid fibrils from medullary carcinoma of the thyroid, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 113.Google Scholar
  228. Sletten, K., Westermark, P., and Natvig, J. B., 1976, Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid, J. Exp. Med. 143: 993–998.PubMedGoogle Scholar
  229. Sletten, K., Westermark, P., and Natvig, J. B., 1980, Senile cardiac amyloid is related to prealbumin, Scand. J. Immunol. 12: 503–506.PubMedGoogle Scholar
  230. Smith, P. P. L., Hutchins, G. M., Moore, G. W., and Humphrey, R. L., 1979, Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloidosis, Am. J. Med. 66: 96–104.PubMedGoogle Scholar
  231. Smith, T. J., Kyle, R. A., and Lie, J. T., 1984, Clinical significance of histopathologic patterns of cardiac amyloidosis, Mayo Clin. Proc. 59: 547–555.PubMedGoogle Scholar
  232. Sohar, E., Pras, M., Heller, J., and Heller, H., 1961, Genetics of familial Mediterranean fever, Arch. Intern. Med. 107: 529–532.Google Scholar
  233. Sohar, E., Gafni, J., Blum, A., Pras, M., and Heller, H., 1963, Primary perireticular (typical) amyloidosis in Israel: Its relation to familial Mediterranean fever, Q. J. Med. 127: 211–223.Google Scholar
  234. Sohar, E., Gafni, J., Pras, M., and Heller, H., 1967, A survey of 470 cases and review of the literature, Am. J. Med. 43: 227–253.PubMedGoogle Scholar
  235. Sousa, A., Coelho, T., and Sequeiros, J., 1990, Sex differences and age-dependent penetrance in FAP-type I, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 128.Google Scholar
  236. St. George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Neve, R. L., Pollen, D., Drachman, D., Growdon, J., Cupples, L. A., Nee, L., Myers, R. H., O’Sullivan, D., Watkins, P. C., Amos, J. A., Deutsch, C. K., Bodfish, J. W., Kinsbourne, M., Feldman, R. G., Bruni, A., Amaducci, L., Foncin, J. F., and Gusella, J. F., 1987a, Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer’s disease, Science 238: 664–666.Google Scholar
  237. St. George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Haines, J. L., Nee, L., Watkins, P. C., Myers, R. H., Feldman, R. G., Pollen, D., Drachman, D., Growdon, J., Bruni, A., Foncin, J.-F., Salmon, D., Frommelt, P., Amaducci, L., Sorbi, S., Piacentini, S., Stewart, G. D., Hobbs, W. J., Conneally, M., and Gusella, J. F., 19876, The genetic defect causing familial Alzheimer’s disease maps on chromosome 21, Science 235: 885–890.Google Scholar
  238. St. George-Hyslop, P., Haines, J. L., Farrer, L. A., Polinsky, R., Van Broeckhoven, C., Goate, A., McLachlan, D. R. C., Orr, H., Bruni, A. C., Sorbi, S., Rainero, I., Foncin, J. F., Pollen, D., Cantu, J. M., Tupler, R., Voskresenskaya, N., Mayeux, R., Growdon, J., Fried, V. A., Myers, R. H., Nee, L., Backhovens, H., Martin, J. J., Rossor, M., Owen, M. J., Mullan, M., Percy, M. E., Karlinsky, H., Rich, S., Heston, L., Montesi, M., Nrotilla, M., Nacmias, N., Gusella, J. F., and Hardy, J. A., 1990, Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder, Nature 347: 194–197.Google Scholar
  239. Strahler, J. R., Rosenblum, B. B., and Hanash, S. M., 1987, Identification and characterization of a human transthyretin variant, Biochem. Biophys. Res. Commun. 148: 471–477.PubMedGoogle Scholar
  240. Sycmore, G. W., Health, H., and Carney, J. A., 1980, Multiple endocrine neoplasia type 2, Clin. Endocrinol. Metab. 9: 299–315.Google Scholar
  241. Tanzi, R. E., Bird, E. D., Latt, S. A., and Neve, R. L., 1987c, The amyloid ß protein gene is not duplicated in brains from patients with Alzheimer’s disease, Science 238: 666–669.PubMedGoogle Scholar
  242. Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St. George-Hyslop, P., Van Keuren, M. L., Petterson, D., Pagan, S., Kurnit, D. M., and Neve, R. L., 19876, Amyloid fi protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science 235: 880–884.Google Scholar
  243. Tanzi, R. E., St. George-Hyslop, P. H., Haines, J. L., Polinsky, R. J., Nee, L., Foncin, J. F., Neve, R. L., McClatchey, A. I., Conneally, P. M., and Gusella, J. F., 1987c, The genetic defect in familial Alzheimer’s disease is not tightly linked to the amyloid ß-protein gene, Science 329: 156–157.Google Scholar
  244. Tawara, S., Nakazato, M., Kangawa, K., Matsuo, H., and Araki, S., 1983, Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type), Biochem. Biophys. Res. Commun. 116: 880–888.PubMedGoogle Scholar
  245. Terry, C. J., Damas, A. M., and Blake, C. C. F., 1990, Computer graphics study of transthyretin mutants associated with familial amyloidotic polyneuropathy, VI Int. Symp. Amyloidosis Progr. Abstr. 1990: 132.Google Scholar
  246. Thomashow, A. J., Angle, W. D., and Morrione, T. G., 1953, Primary cardiac amyloidosis, Am. Heart J. 46: 895–905.PubMedGoogle Scholar
  247. Tomlinson, B. E., Blessed, G., and Roth, M., 1968, Observations on the brains of non-demented old people, J. Neurol. Sci. 7: 331–356.PubMedGoogle Scholar
  248. Tsuzuki, T., Mita, S., Maeda, S., Araki, S., and Shimada, K., 1985, Structure of the human prealbumin gene, J. Biol. Chem. 260: 12224–12227.PubMedGoogle Scholar
  249. Tu, G., Cole, T., Southwell, B. R., and Schreiber, G., 1990, Expression of the genes for transthyretin, cystatin C and 0 A4 amyloid precursor protein in sheep choroid plexus during development, Dev. Brain Res. 55: 203–208.Google Scholar
  250. Ueno, S., Uemichi, T., Yorifuji, S., and Tarui, S., 1990a, A novel variant of transthyretin (Tyrll4 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases, Biochem. Biophys. Res. Commun. 169: 143–147.PubMedGoogle Scholar
  251. Ueno, S., Uemichi, T., Takahashi, N., Soga, F., Yorifuji, S., and Tarui, S., 19906, Two novel variants of transthyretin identified in Japanese cases with familial amyloidotic polyneuropathy: transthyretin (Glu42 to Gly) and transthyretin (Ser50 to Arg), Biochem. Biophys. Res. Commun. 169: 1117–1121.Google Scholar
  252. Van Allen, M. W., Frohlich, J. A., and Davis, J. R., 1969, Inherited predisposition to generalised amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy and peptic ulcer, Neurology 19: 10–25.PubMedGoogle Scholar
  253. Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, W., Wehnert, A., Vegter-Van der Vlis, M., and Roos, R. A. C., 1990, Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch), Science 248: 1120–1122.Google Scholar
  254. Van Duinen, S. G., Castano, E. M., Prelli, F., Bots, G. T. A. B., Luyendijk, W., and Frangione, B., 1987, Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease, Proc. Natl. Acad. Sci. USA 84: 5991–5994.PubMedGoogle Scholar
  255. Van Jaarsveld, P. P., Edelhoch, H., Goodman, D. S., and Robbins, J., 1973, The interaction of human plasma retinol-binding protein with prealbumin, J. Biol. Chem. 248: 4698–4705.PubMedGoogle Scholar
  256. Van Nostrand, W. E., Wagner, S. L., Suzuki, M., Choi, B. H., Farrow, J. S., Geddes, J. W., Cotman, C. W., and Cunningham, D. D., 1989, Protease nexin-II, a potent anti- chymotrypsin, shows identity to amyloid /3-protein precursor, Nature 341: 546–549.PubMedGoogle Scholar
  257. Vasily, D. B., Shyamsunder, G. B., and Uhlin, S. R., 1978, Familial primary cutaneous amyloidosis. Clinical, genetic, and immunofluorescent studies, Arch. Dermatol. 114: 1173–1176.PubMedGoogle Scholar
  258. Vinters, H. V., Miller, B. L., and Pardridge, W. M., 1988, Brain amyloid and Alzheimer disease, Ann. Intern. Med. 109: 41–54.PubMedGoogle Scholar
  259. Von Eckardstein, A., Funke, H., Henke, A., Altland, K., Benninghoven, A., and Assmann, G., 1989, Apolipoprotein A-l variants: Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-l, J. Clin. Invest. 84: 1722–1730.Google Scholar
  260. Wakasugi, S., Maeda, S., Shimada, K., Nakashima, H., and Migita, S., 1985, Structural comparisons between mouse and human prealbumin, J. Biochem. 98: 1707–1714.PubMedGoogle Scholar
  261. Wallace, M. R., Naylor, S. L., Kluve-Beckerman, B., Long, G. L., McDonald, L., Shows, T. B., and Benson, M. D., 1985, Localization of the human prealbumin gene to chromosome 18, Biochem. Biophys. Res. Commun. 129: 753–758.PubMedGoogle Scholar
  262. Wallace, M. R., Dwulet, F. E., Conneally, P. M., and Benson, M. D., 1986, Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis, J. Clin. Invest. 78: 6–12.PubMedGoogle Scholar
  263. Wallace, M. R., Dwulet, F. E., Williams, E. C., Conneally, P. M., and Benson, M. D., 1988, Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis, J. Clin. Invest. 81: 189–193.PubMedGoogle Scholar
  264. Wattendorff, A. R., Bots, G. T., Went, L. N., and Endtz, L. J., 1982, Familial cerebral amyloid angiopathy presenting as recurrent cerebral hemorrhage, J. Neurol. Sci. 55: 121–135.PubMedGoogle Scholar
  265. Westermark, G. T., Sletten, K., and Westermark, P., 1988, The structure of protein AA and its correlation to the tissue distribution of amyloid, in: Amyloid and Amyloidosis ( T. Isobe, S. Araki, F. Uchino, S. Kito, and E. Tsubura, eds.), Plenum Press, New York, pp. 199–203.Google Scholar
  266. Westermark, P., Johansson, B., and Natvig, J. B., 1979, Senile cardiac amyloidosis: Evidence of two different amyloid substances in the aging heart, Scand. J. Immunol. 10: 303–308.PubMedGoogle Scholar
  267. Westermark, P., Pitkanen, P., Benson, L., Vahlquist, A., Olofsson, B. O., and Corn well, G. G., Ill, 1985, Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis, Lab. Invest. 52: 314–318.PubMedGoogle Scholar
  268. Westermark, P., Sletten, K., and Olofsson, B. O., 1987, Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy, Clin. Exp. Immunol. 69: 695–701.PubMedGoogle Scholar
  269. Westermark, P., Sletten, K., Johansson, B., and Cornwell, G. G., Ill, 1990, Fibril in senile systemic amyloidosis is derived from normal transthyretin, Proc. Natl. Acad. Sci. USA 87: 2843–2845.PubMedGoogle Scholar
  270. Whitehead, A. S., Skinner, M., Bruns, G. A. P., Costello, W., Edge, M. D., Cohen, A. S., and Sipe, J. D., 1984, Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with familial amyloid polyneuropathy, Mol. Biol. Med. 2: 411–423.PubMedGoogle Scholar
  271. Williamson, L. M., Hall, D., Mehtz, R., Reeves, W. G., and Robinson, B. H., 1982, Familial Hibernian fever, Q. J. Med. 51: 469–480.PubMedGoogle Scholar
  272. Wong, C. W., Quaranta, V., and Glenna, G. G., 1985, Neurotic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related, Proc. Natl. Acad. Sci. USA 82: 8729–8732.PubMedGoogle Scholar
  273. Woo, P., Sipe, J., Dinarello, C. A., and Colten, H. R., 1987a, Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells, J. Biol. Chem. 262: 15790–15795.PubMedGoogle Scholar
  274. Woo, P., Robson, M., O’Brien, J., and Ansell, B. M., 1987, A genetic marker for systemic amyloidosis in juvenile arthritis, Lancet 2: 767–769.PubMedGoogle Scholar
  275. Wright, J. R., and Calkins, F., 1975, Amyloid in the aged heart: Frequency and clinical significance, J. Am. Geriat. Soc. 23: 97–103.PubMedGoogle Scholar
  276. Wright, M. D., Calkins, E., Breen, W., Stolte, G., and Schultz, R. T., 1969, Relationship of amyloid to aging. Review of the literature and systematic study of 83 patients derived from a general hospital population, Medicine 48: 39–60.PubMedGoogle Scholar
  277. Yamada, M., Tsukagoshi, H., Satoh, J., Ishiai, S., Nakazato, M., Furuya, H., Sasaki, H., Sakaki, Y., and Yokota, T., 1987, “Sporadic” prealbumin-related amyloid polyneuropathy: Report of two cases, J. Neurol. 235:69–73.Google Scholar
  278. Yamada, M., Tsukagoshi, H., Wada, Y., Otomo, E., Hayakawa, M., Thorsteinsson, L., and Jensson, O., 1989, Absence of cystatin C amyloid in the cerebral amyloid angiopathy, senile plaque and extra CNS amyloid deposits of aged Japanese, Acta Neurol. Scand. 79: 504–509.PubMedGoogle Scholar
  279. Yan, C., Costa, R. H., Darnell, J. E., Jr., Chen, J., and Van Dyke, T. A., 1990, Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice, EMBO J. 9: 869–878.PubMedGoogle Scholar
  280. Yoshioka, K., Furuya, H., Sasaki, H., Saraiva, M. J. M., Costa, P. P., and Sakaki, Y., 1989, Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val-Met mutation most common to the disease, Hum. Genet. 82: 9–13.PubMedGoogle Scholar
  281. Youssoufian, H., Antonarakis, S., Bell, W., Griffin, A. M., and Kazazian, H. H., 1990, Nonsense and missense mutations in hemophilia A: Estimate of the relative mutation rate at CG dinucleotides, Am. J. Hum. Genet. 42: 718–725.Google Scholar
  282. Zannis, V. I., and Breslow, J. L., 1985, Genetic mutations affecting human lipoprotein metabolism, Adv. Hum. Genet. 14: 125–215.PubMedGoogle Scholar
  283. Zemer, D., Revach, M., Pras, M., Modan, B., Schor, S., Sohar, E., and Gafni, J., 1974, A controlled trial of colchicine in preventing attacks of familial Mediterranean fever, TV. Engl. J. Med. 291: 932–937.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Daniel R. Jacobson
    • 1
    • 2
    • 3
    • 4
  • Joel N. Buxbaum
    • 1
    • 2
    • 3
    • 4
  1. 1.Medical and Research ServicesNew York University Medical CenterNew YorkUSA
  2. 2.New York Veterans Affairs Medical CenterNew York University Medical CenterNew YorkUSA
  3. 3.Department of MedicineNew York University Medical CenterNew YorkUSA
  4. 4.Department of PathologyNew York University Medical CenterNew YorkUSA

Personalised recommendations